Health Care · Laboratory Analytical Instruments

MTD Mettler Toledo SEC Filings & Insider Trading Activity 2026

company
CIK 1037646102 filings
S&P 500

MTD at a glance

Mettler Toledo (MTD, SEC CIK 1037646) filed its latest 10-K annual report on February 6, 2026, a 10-Q quarterly report on November 6, 2026, an 8-K current report on November 5, 2026 and Form 4 insider filings as recently as November 16, 2026. SignalX summarizes each filing with AI and tracks the company's insider trades and institutional holders.

  • For the fiscal year ended December 31, 2025 (FY2025), Mettler Toledo (MTD) reported revenue of $4.0 billion (up 4.0% from FY2024) and net income of $869.2 million. Diluted EPS was $42.05.
  • As of September 30, 2026, 37 institutional investment managers tracked by SignalX reported holding Mettler Toledo (MTD) shares worth $11.7 billion in 13F-HR filings.
  • In the last 90 days, MTD insiders reported 0 open-market purchases ($0) and 3 open-market sales ($2.1M) on Form 4, a net sale of $2.1M.

Source: SEC EDGAR (XBRL financial data, 13F-HR and Form 4 filings).

Revenue · FY2025
$4.0B
+4.0% vs prior year
Insiders · 90 days
0 buys · 3 sells
Net −$2.1M
13F holders
37 funds
$11.7B · +0 vs prior quarter
Latest 8-K
Nov 5, 2026
Item 2.02

AI 10-K Annual Report Analysis

Latest 10-K, fiscal year ended Dec 31, 2025

Full analysis →

Risk Factors

  • U.S.-China geopolitical tensions causing 16% sales, 29% segment profit, 29% production exposure in China with tariff increases and supply chain risks
  • Ukraine war and Middle East conflict disrupting supply chains, increasing costs, reducing shipping capacity, and heightening global economic uncertainty
  • Single-location manufacturing dependencies in China, Europe, and U.S. risking significant production disruptions from labor unrest, natural disasters, or cybersecurity attacks
  • Competition from larger firms and emerging market low-cost competitors accelerating AI and digitalization adoption, pressuring margins and market share
  • Currency risk with 1% Swiss franc strengthening estimated to reduce earnings before tax by $2.8-$3.1 million annually, and 5% USD weakening increasing debt by $53.7 million

Management Discussion & Analysis

  • Revenue $4.0B in 2025, up 4% YoY from $3.9B in 2024; local currency sales up 3% in 2025 and 2024
  • Gross margin 59.4% in 2025 vs 60.1% in 2024; product margin 61.1% vs 62.1%, service margin 54.4% vs 53.7%
  • Best segment: U.S. Operations, sales $1.50B (+5%), profit $375M (-5%); Worst: Swiss Operations, sales $211M (-4%), profit $284M (+1%)
  • R&D 5.0% of sales, SG&A 24.8%; Interest expense $68.5M (down); Restructuring charges $17.9M (down); acquisitions expanded service revenue by ~1%
  • Management cites ongoing risks from tariffs ($50M costs in 2025), geopolitical uncertainty; growth drivers automation, digitalization, emerging markets

Business Overview

  • Core business: Precision instruments and analytical equipment manufacturing for laboratory and industrial use
  • New share repurchase program authorization of $2.75 billion in November 2025, adding to $3.7 billion remaining availability
  • Share repurchase spending $800 million in 2025 on 646,608 shares at average $1,237.18 per share versus $850 million in 2024
  • Total shares repurchased since 2004: 33.0 million at average price $320.91, cost $10.6 billion through 2025
  • Inflation Reduction Act excise tax $7.4 million in 2025, slightly reducing shareholders' equity

AI summary of the MTD 10-K filed . Generated from the filing text; verify against the original.View on SEC EDGARHow to read a 10-K

AI 10-Q Quarterly Report Analysis

Latest 10-Q, quarter ended Sep 30, 2026

Risk Factors

  • No material changes to previously disclosed risk factors for the three and nine months ended September 30, 2026
  • Carried-forward risks remain those disclosed in the December 31, 2025 Form 10-K

Management Discussion & Analysis

  • Revenue $1.094B, up 6% YoY from $1.030B
  • Gross margin 59.8% vs 59.2% YoY, net earnings margin 22.5% vs 21.1%
  • Chinese Operations strongest: sales $303.6M, up 19%; Food retailing weakest, sales down 1%
  • Operating cash flow $758.8M for nine months vs $730.2M; share repurchases $638.7M
  • Outlook: tariff changes, Iran conflict, Middle East uncertainty and inflation threaten demand and results

AI summary of the MTD 10-Q filed . Generated from the filing text; verify against the original.View on SEC EDGAR10-K vs 10-Q vs 8-K

AI 8-K Current Report Analysis

The most recent material events, by 8-K item

Filed Nov 5, 2026Full analysis →

Item 2.02: Results of Operations and Financial Condition

  • Q3 and nine-month FY2026 results announced for periods ended September 30, 2026
  • Key financial figures and management commentary reside in Exhibit 99.1, the accompanying earnings release

Item EX-99.1: Item EX-99.1

  • Q3 sales $1.094B, up 6%; Asia/Rest of World led growth at 16%, versus 3% Americas and flat Europe
  • Q3 diluted EPS $12.29, up from $10.57; adjusted EPS $12.57, up 13%, with adjusted operating margin 30.5%
Filed Aug 3, 2026Full analysis →

Item 5.02: Departure/Appointment of Directors or Principal Officers

  • Natalia Shuman appointed independent director effective August 3, 2026
  • Board expanded from nine to ten directors, increasing governance capacity

Item 7.01: Regulation FD Disclosure

  • Press release announces Ms. Shuman’s appointment, creating a management succession and leadership-change consideration
  • Investors should review Exhibit 99.1 for her role, effective date and relevant qualifications
Filed Jul 30, 2026Full analysis →

Item EX-99.1: Item EX-99.1

  • Q2 sales $1.027B, up 4%; organic local-currency growth 4% excluding acquisitions and customer tariff refunds
  • Adjusted EPS $11.46, up 14%; GAAP diluted EPS $11.55 versus $9.76

Item 2.02: Results of Operations and Financial Condition

  • Q2 and first-half fiscal 2026 results announced for periods ended June 30, 2026
  • Exhibit 99.1 contains the earnings release, including reported financial results and management commentary

AI summaries of MTD 8-K current reports filed with the SEC. What 8-K item codes mean

SignalX for MTD

Don't miss the next MTD filing

  • Alerts as it files. A push when MTD files an 8-K or an insider trades.
  • Fund moves. Which tracked funds opened, added or cut MTD, by share count.
  • Ask anything. An AI agent that reads every MTD filing and answers with sources.

MTD alerts on your phone. Follow it in the SignalX Android app.

Get it on Google Play

Recent Insider Transactions (Form 4)

Latest reported trades by officers, directors and 10% owners

InsiderTypeDatePrice
Keller GerryANov 12, 2026-
Wong Ann Ping RichardANov 12, 2026-
Vadala ShawnANov 12, 2026-
Kaltenbach PatrickANov 12, 2026-
Wittorf OliverANov 12, 2026-
SALICE THOMAS PANov 10, 2026-
Kaltenbach PatrickANov 10, 2026-
Zhang IngridANov 10, 2026-

Financial Summary
XBRL

Annual financial summary from SEC XBRL data
MetricFY2023FY2024FY2025
Profitability
Revenue-$3.9B$4.0B
Gross Profit$2.2B$2.3B$2.4B
Net Income-$863.1M$869.2M
Gross Margin-60.1%59.4%
Net Margin-22.3%21.6%
Balance Sheet
Total Assets$3.4B$3.2B$3.7B
Equity--$126.9M-$23.6M
ROE--680.2%-3677.4%
Per Share
EPS$35.90$40.48$42.05
Cash Flow
Operating CF-$968.3M$955.8M
CapEx$105.3M$103.9M$107.1M

Source: XBRL data in Mettler Toledo (MTD)'s 10-K filings on SEC EDGAR, in USD. Compare across companies →

13F Fund Holdings: Quarterly Trend

Latest: Q3 2026

Aggregate MTD share value held by 13F filers tracked by SignalX, by quarter.

Quarterly totals table
MTD shares held by 13F filers tracked by SignalX, by quarter
QuarterFundsTotal value
Q3 202637$11.68B
Q2 202637$10.78B
Q1 202637$11.14B
Q4 202532$11.90B
Q3 202534$11.73B
Q2 202531$10.81B
Q1 202533$7.54B
Q4 202430$6.61B
Position changes: Q2 2026 → Q3 2026
Top Buyers
Top Sellers
Closed Positions

Source: 13F-HR filings on SEC EDGAR (aggregated from 271 fund-quarter rows). Reflects only 13F filers tracked by SignalX, not the full institutional ownership universe. How 13F filings work

MTD filing archive

AI analysis pages for each 10-K, 10-Q and 8-K

Latest 2026 SEC Filings: 10-K, 10-Q, 8-K & Form 4

FormFiling dateAnalysisSEC
4Nov 16, 2026--
4Nov 16, 2026--
4Nov 16, 2026--
4Nov 16, 2026--
4Nov 16, 2026--
4Nov 12, 2026--
4Nov 12, 2026--
4Nov 12, 2026--
4Nov 12, 2026--
4Nov 12, 2026--
4Nov 12, 2026--
4Nov 12, 2026--
4Nov 12, 2026--
4Nov 12, 2026--
4Nov 12, 2026--
4Nov 12, 2026--
4Nov 12, 2026--
4Nov 12, 2026--
4Nov 12, 2026--
4Nov 12, 2026--
4Nov 12, 2026--
4Nov 10, 2026--
10-QNov 6, 2026Analysis
8-KNov 5, 2026Analysis-
4Sep 1, 2026--

Related Health Care companies

All Health Care →

MTD SEC filings: frequently asked questions

Are MTD insiders buying or selling?

In the last 90 days, Mettler Toledo (MTD) officers, directors and 10% owners reported no open-market purchases and 3 open-market sales worth $2.1 million by 2 insiders on Form 4. Many insider sales are pre-planned or for taxes, so purchases usually carry more information.

Which institutions hold MTD stock?

As of September 30, 2026, the largest Mettler Toledo (MTD) holders among the 13F filers tracked by SignalX were BlackRock ($2.7 billion), Vanguard Capital Management LLC ($2.0 billion), Vanguard Portfolio Management LLC ($1.6 billion), State Street Corp ($1.4 billion), Morgan Stanley ($770.1 million). 13F-HR reports are filed up to 45 days after each quarter ends.

What was MTD's revenue in fiscal year 2025?

For the fiscal year ended December 31, 2025 (FY2025), Mettler Toledo (MTD) reported revenue of $4.0 billion (up 4.0% from FY2024) and net income of $869.2 million. Diluted EPS was $42.05. The figures come from the XBRL data in the 10-K.

What are the main risks in MTD's latest 10-K?

In the 10-K filed February 6, 2026, Mettler Toledo (MTD) flagged: U.S.-China geopolitical tensions causing 16% sales, 29% segment profit, 29% production exposure in China with tariff increases and supply chain risks. Ukraine war and Middle East conflict disrupting supply chains, increasing costs, reducing shipping capacity, and heightening global economic uncertainty. (AI summary of the Risk Factors section.)

What did MTD report in its latest 8-K?

Mettler Toledo (MTD) filed an 8-K on November 5, 2026 reporting Item 2.02 (Results of Operations and Financial Condition). Q3 and nine-month FY2026 results announced for periods ended September 30, 2026.

What are the latest MTD SEC filings?

Mettler Toledo (MTD) filed its latest 10-K annual report on February 6, 2026, a 10-Q quarterly report on November 6, 2026, an 8-K current report on November 5, 2026 and a Form 4 insider filing on November 16, 2026.

What is MTD's SEC CIK number?

Mettler Toledo (MTD)'s SEC Central Index Key (CIK) is 1037646. EDGAR lists every MTD filing under that number.

Ask anything about MTD

The research agent reads MTD's filings, financials, insider trades and 13F holders, then answers with sources.